about
JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugsSystematic variation in gene expression patterns in human cancer cell linesHigh resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMinerA mass spectrometric-derived cell surface protein atlasThe Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityA genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancersDNA fingerprinting of the NCI-60 cell line panel.Characterization of Human Cancer Cell Lines by Reverse-phase Protein ArraysIdentification of cancer cell-line origins using fluorescence image-based phenomic screening.The metabolic demands of cancer cells are coupled to their size and protein synthesis ratesOrigin of the U87MG glioma cell line: Good news and bad news.U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells.Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.DNA fingerprinting of glioma cell lines and considerations on similarity measurements.Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferationThe exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCRA landscape of pharmacogenomic interactions in cancer.Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.A map of mobile DNA insertions in the NCI-60 human cancer cell panel.Global proteome analysis of the NCI-60 cell line panel.GL15 and U251 glioblastoma-derived human cell lines are peculiarly susceptible to induction of mitotic death by very low concentrations of okadaic acid.Rare-type mutations of MMAC1 tumor suppressor gene in human glioma cell lines and their tumors of origin.Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway.A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations.Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.Absence of HeLa cell contamination in 169 cell lines derived from human tumors.IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomasBanding patterns in human glioma cell lines.Overexpressed Skp2 within 5p amplification detected by array-based comparative genomic hybridization is associated with poor prognosis of glioblastomas.The deficient density-dependent growth control of human malignant glioma cells and virus-transformed glia-like cells in culture.Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines.Tumor-specific membrane antigens in established cell lines from gliomas.Human tumor lines for cancer research.Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas.Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas.
P4510
Q54752556-B9735077-C4B0-4160-BA56-FCA9B500D30FQ54900255-0C08C14A-C6DA-49FB-85FB-D240073AC9CEQ54972517-D6B78F18-A050-4A67-95FE-0C96AAB2C092Q54973551-F6BC467E-0CCE-475B-9B6E-20420B1F3094Q54973553-3127676E-7D75-4C6E-8EDE-B31FA947830BQ54973555-603D699F-5C02-4C17-9561-35409807A2FEQ54973556-638769E9-482B-4743-A55A-11EF291E3ED1Q54973575-1182E774-2212-4203-A90C-97797A94D3B7Q54973630-D1E22BA6-45E4-4EF9-9A8D-198B76F42A0A
P3432
Q27025525-AC35559D-A684-4951-97AF-85060316BDD1Q28145747-6905504A-0124-4B01-8876-14A6475E6909Q28541555-28729DE2-AC96-4699-A8C9-CD48F61A6B84Q28546580-91FEB0F4-9E97-410D-91F8-144E989B3ADFQ29547693-7B90A7AF-7B44-429A-9600-34D25D3364D6Q30434796-650D7E43-6CEA-44E6-A679-07D0D5A3639DQ33608214-6259A09F-1A65-4727-9765-41F4D2EAEF58Q33882864-3A39EF13-1C5E-41E8-A2A7-2829FAA49495Q34182256-7A5DFF16-7037-40CB-926B-8D5E5606084DQ34258905-4DDB5B55-2CF5-419C-A5E8-13132A579319Q34539119-4BBCFEBB-2757-4B17-9CA4-7E2C07EFE0A3Q35000404-19BEFEBB-6A4E-4F52-98D9-E5A5A96A98F4Q35609041-0565C78C-F327-446D-827A-9B5107389BF2Q36010078-210C0589-EE5A-4ED8-86A3-C5FF592FADF4Q36247943-2A765A5C-2CD0-4BC8-870A-6419A6254AD5Q36477750-351DD78A-F168-4FC0-A983-12A67D4692FAQ36971433-BAA69350-3279-4672-BF16-C334DEC88D65Q37064887-4163FAB3-38ED-4401-B604-39A8C7485DE9Q37140236-3270A486-0CB0-4870-8C51-B5B93AB68F98Q37250634-6114F560-507B-4402-AC04-538E5ECD763CQ37380123-A53C83D1-DE71-4608-97BA-810A6EC59A20Q39112561-EC48F35C-9CF5-4A3C-8361-F5A2625C032AQ40334182-7D45CC8E-A495-458A-B891-B9D65D917270Q40919390-418B7773-0D55-4EBD-AD91-0B8809E38BACQ41104111-292A7018-EB65-4C03-B597-0487998B045EQ41170835-081D633D-7FB6-4A2E-8FB9-846E06EA7F79Q41679901-AE46EBD1-EA4A-4E6C-94AD-51EA63EA0C29Q41761715-48C76B17-D126-4A6F-839E-2575038C3035Q42164790-010A54D3-5517-4432-BB42-02F953C4C14BQ42802060-73F89A69-4F91-4F90-BECE-0D524E9AE209Q42803466-8A52AED8-6862-4D4B-8ED5-7768054ED8A3Q45826531-CC13A1B6-D5E5-4918-9ABF-0E6B6B4F4BD2Q48154511-EFC14BF8-626B-48BE-B2BB-A87B9AA5796AQ48536460-9623FF9C-BE8C-4318-B386-C247ED64492FQ52826141-AB86C2F4-7273-4B50-A598-664B51D2818BQ52826614-E5918D67-B825-453D-80C8-B70742B33762Q52832727-6FB661C9-CC91-4C46-9C77-FE357CBD06F4
P4510
description
Zelllinie
@de
ceall-líne
@ga
cell line
@en
cellijn van een U-251MG
@nl
lignée cellulaire
@fr
name
U-251MG
@de
U-251MG
@en
U-251MG
@fr
U-251MG
@ga
U-251MG
@nl
type
label
U-251MG
@de
U-251MG
@en
U-251MG
@fr
U-251MG
@ga
U-251MG
@nl
altLabel
251 MG
@en
251MG
@en
U-251 MG
@en
U-251
@en
U-251-MG
@en
U-251_MG
@en
U251
@en
U251-MG
@en
U251MG
@en
U251n
@en
prefLabel
U-251MG
@de
U-251MG
@en
U-251MG
@fr
U-251MG
@ga
U-251MG
@nl